[Gut microbiota in patients with relapsing-remitting multiple sclerosis].

Area of Science:

• Microbiology
• Neuroscience
• Gastroenterology

Background:

• The human body hosts a vast array of microorganisms, collectively known as the microbiota, which play crucial roles in health and disease.
• The intestinal microbiota, encompassing bacteria, fungi, and viruses, is vital for digestion, vitamin synthesis, and maintaining the gut-brain axis.
• The gut-brain axis, a bidirectional communication network between the gut microbiota and the central nervous system, is a key area of research for understanding systemic health and neurological disorders.

Approach:

• This review synthesizes current scientific understanding of the gut microbiota's role in human health.
• It examines the composition of the bacteriome, mycobiome, and virome within the context of the gut-brain axis.
• The article specifically focuses on recent findings related to microbiota alterations in patients with relapsing-remitting multiple sclerosis.

Key Points:

• The intestinal microbiota significantly influences the gut-brain axis, affecting neuroendocrine pathways and central nervous system function.
• Alterations in gut microbial composition are increasingly implicated in the pathology of neurological conditions.
• Targeting the gut microbiota presents a potential therapeutic avenue for managing diseases such as neurodegenerative and demyelinating disorders.

Conclusions:

• The gut-brain axis is a critical interface linking microbial communities to neurological health.
• Further research into the gut microbiota's composition and function in diseases like multiple sclerosis is warranted.
• Microbiota-targeted interventions may offer novel adjunctive therapies for neurological conditions.